ACTIGEN®

ACTIGEN® is the unique bovine collagen type I surface treatment that significantly promotes osseointegration of dental implants. Dental implants boasting this surface treatment are Class III medical devices available only from selected and certified implant manufacturers.

UBGEN® has developed the only bioactive surface treatment, with an osteoinductive effect, with the ability to:

Stimulate platelet activity.
Prepare the implant surface to be rapidly colonised by bone.
Increase the area of bone/implant contact (Bone Implant Contact – BIC).
Reduce healing time.

01 Acceleration of osseointegration

The collagen in ACTIGEN® acts as a kind of bridge between the implant and the bone, facilitating the adhesion of bone cells and stimulating the formation of new bone tissue.

02 Increased bone-to-implant contact (BIC)

Thanks to collagen, a wider and more stable contact is created between the implant and the bone, improving the implant’s long-term strength.

03 Stimulation of cellular activity

Collagen induces bone cells to become more active, promoting the production of new bone matrix and tissue regeneration.

04 Reduced healing time

The acceleration of the osseointegration process results in faster healing times for the patient.

05 Increased security

As a class III medical device, ACTIGEN® is subjected to the strictest controls, ensuring a high standard of safety.

Features

Composition: Based on bovine collagen type I, the main organic constituent of bone.
How it works: Collagen creates a bioactive surface that interacts with bone cells, stimulating their activity and promoting the formation of new bone tissue.
Scientific results: In vitro and in vivo studies have demonstrated the effectiveness of ACTIGEN® in accelerating osseointegration and improving the quality of peri-implant bone tissue.
Competitive advantage: ACTIGEN® represents an innovation in the field of implantology, offering clinicians and patients a more effective and safer treatment.